Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 25, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 27, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-002816
Filed / recorded
Feb 27, 2026, 11:34 PM UTC
Added to OQRO
Oct 1, 2026, 11:17 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
PFIZER INC
Issuer CIK
78003
Ticker
PFE
Reporting person
Michael Mcdermott
Relationship
Officer
Officer title
Executive Vice President
Security
Stock Appreciation Rights
Table
Derivative (Table II)
Transaction date
Feb 25, 2026
Transaction code
M
Shares / units
37,925
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.